Physician profile
Stephen Michael Settle
NPI 1982628137
$37,181.75
in general payments reported to CMS, 2019-2025
15 companies · $2,760 in 2025
The $2,760 reported for 2025 was more than what 76% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $2,471 · 2021: $1,802 · 2022: $8,761 · 2023: $2,524 · 2024: $2,243 · 2025: $2,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,151 · Travel and Lodging: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,151.27 |
| Travel and Lodging | $375.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $21,622.27 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic, INC. | $8,287.86 | 2021-2024 | Ellipsys Vascular Access System, Abre, Heli-Fx Endoanchor System |
| Getinge USA Sales, LLC | $3,215.67 | 2019-2025 | Vasoview Hemopro 2 |
| Reflow Medical INC | $1,738.15 | 2023-2025 | |
| Penumbra, INC. | $743.11 | 2022-2025 | Penumbra System, Indigo System |
| Laminate Medical Technologies INC. | $336.48 | 2019-2021 | |
| Atricure, INC. | $304.37 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Synergy Ablation System |
| Bard Peripheral Vascular, INC. | $268.16 | 2019-2021 | |
| Lemaitre Vascular, INC. | $232.33 | 2023-2025 | Artegraft Vascular Graft, Restoreflow, Xenosure Biologic Patch |
| Cook Medical LLC | $139.64 | 2019-2025 | Icast Covered Stent System, 6mmx22mmx120cm, Cook, Zenith Alpha |
| Becton, Dickinson and Company | $130.89 | 2019 | |
| Boston Scientific Corporation | $62.03 | 2019-2025 | Eluvia |
| Shockwave Medical, INC | $54.00 | 2021 | |
| Medtronic Vascular, INC. | $31.58 | 2019 | |
| Oyster Point Pharma, INC. | $15.21 | 2024 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Settle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.